Showing results (41-50 of 240) with videos related to
Sort By:
Pageof 24
Naunyn-Schmiedeberg'S Archives of Pharmacology|March 12, 2025
The bioactivity of atraric acid as an inducer of cellular senescence in prostate cancer cells is retained by lipophilic derivativesAdina Asara Baniahmad, Golnaz Atri Roozbahani, Manfred Jung, et al.Bioorganic & Medicinal Chemistry|February 15, 2011
Computer- and structure-based lead design for epigenetic targetsRalf Heinke, Luca Carlino, Srinivasaraghavan Kannan, et al.Medicinal Research Reviews|January 18, 2017
The Current State of NAD<sup>+</sup> -Dependent Histone Deacetylases (Sirtuins) as Novel Therapeutic TargetsMatthias Schiedel, Dina Robaa, Tobias Rumpf, et al.Biological Chemistry|June 24, 2003
Trichostatin A and structurally related histone deacetylase inhibitors induce 5-lipoxygenase promoter activityNiko Klan, Sabine Seuter, Nicole Schnur, et al.Phytochemistry|August 22, 2009
The ergot alkaloid gene cluster: functional analyses and evolutionary aspectsNicole Lorenz, Thomas Haarmann, Sylvie Pazoutová, et al.Bioconjugate Chemistry|October 6, 2007
Development of albumin-binding camptothecin prodrugs using a Peptide positional scanning libraryBjörn Schmid, André Warnecke, Iduna Fichtner, et al.Epigenetics|January 11, 2017
Cellular analysis of the action of epigenetic drugs and probesMirjam Hau, Fides Zenk, A Ganesan, et al.Methods in Molecular Biology (Clifton, N.J.)|February 6, 2013
Nonradioactive in vitro assays for histone deacetylasesAlexander-Thomas Hauser, Julia M Gajer Née Wagner, Manfred JungMolecular Cancer Therapeutics|September 19, 2007
Characterization of novel inhibitors of histone acetyltransferasesElena D Eliseeva, Vassil Valkov, Manfred Jung, et al.Journal of the American Heart Association|June 14, 2022
Histone Deacetylase 6 Inhibitor JS28 Prevents Pathological Gene Expression in Cardiac MyocytesVivien Ngo, Bernd K Fleischmann, Manfred Jung, et al.Pageof 24